Current Affairs · Science and Medicine
The oral pill 'Mitapivat', approved by the U.S. Food and Drug Administration (FDA) for expanded indications, is a breakthrough treatment for which of the following genetic blood disorders?
Verified Solution4 OptionsUpdated: October 2026👁️1 View
Share:
- 1Hemophilia
- 2Thalassemia✓
- 3Aplastic Anaemia
- 4Sickle Cell Disease
Correct answer
Thalassemia
Download Single Question PDF
Save this question and verified answer as a clean study sheet with live clickable link.
👥
Share with Friends & Study Groups
Challenge your peer aspirants on WhatsApp or Telegram to solve this question!
Online Test Series
Start Free Mock Test →Preparing for Current Affairs?
Practice full-length mock tests with real exam timers, instant score analysis, and all-India ranking.
Chapter Practice
Practice Science and Medicine MCQs →Want more practice questions on Science and Medicine?
Solve complete topic-wise tests with detailed solutions on GkGet.
Related Practice Questions
Recommended practice questions in Current Affairs · Science and Medicine